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ABSTRACT: To better understand the role of trisomy 8 in myelodysplastic syndrome (MDS), we performed 
a multiparameter analysis combining conventional chromosome studies (CCS), fluorescence in situ hy- 
bridization (FISH), and bone marrow (BM) culture studies in two patients with MDS evolving into acute 
myeloid leukemia (AML). 
A mosaicism ofa cytogenetically normal clone and a clone with trisomy 8 was detected in both patients 
throughout he course of the disease, a finding confirmed by FISH on BM cells. The relative size of the 
trisomic clone increased from 52% to 71% (p < 0.0001) and from 53% to 69% (p = 0.001) of all BM cells 
at the time of the leukemic switch in patients 1 and 2, respectively. 
Combined FISH and immunophenotyping of BM cells showed involvement of the granulomonocytic 
lineage in patient 1 and involvement of erythroid cells as well as of the granulomonocytic lineage in pa- 
tient 2. Only disomic lymphocytes were detected in both patients. 
FISH on single hemopoietic colonies grown in semisolid media detected trisomic CFU-GM and disomic 
BFU-E in patient 1, whereas a proportion of CFU-GM and BFU-E deriving from the trisomic clone was 
detected in patient 2. However, the percent of trisomic colonies was lower than the percent of involved 
granulomonocyte precursors and involved erythroblasts, as detected by combined FISH and im- 
munophenotyping on fresh BM samples. 
We have thus shown heterogeneity of lineage involvement by trisomy 8 in MDS undergoing transforma- 
tion into AML. Although preferential growth of disomic clones may occur in vitro, the finding of an in- 
creased size of the trisomic clone at the time of leukemic switch suggests that these cells had proliferative 
advantage in vivo over cells without trisomy 8. 
INTRODUCTION 
A number of non-random chromosome changes have been 
described in myelodysplastic syndrome (MDS) [1], reflect- 
ing the heterogeneity of the clinicobiologic features of this 
myeloid neoplasia characterized byineffective hemopoiesis 
resulting in progressive cytopenia ffecting one or more cell 
lineages. Trisomy 8 is one of the most frequently occurring 
numerical change in MDS, and does not appear to be re- 
stricted to any of the cytologic subsets identified by the FAB 
group in 1982 [2]. 
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Cytogenetic studies of different cell populations obtained 
by separation over a density gradient, as well as chromosome 
analysis of single hemopoietic colonies, documented that 
trisomy 8 may involve both the erythroid series and the 
granulomonocytic lineage [3, 4]. However, recent investiga- 
tions combining fluorescence in situ hybridization (FISH) 
and membrane immunophenotyping to detect numerical 
aberrations in interphase nuclei documented the heteroge- 
neity of distribution of this chromosome anomaly in the 
different hemopoietic lineages [5, 6]. 
Consequently, the biologic significance of trisomy 8 in 
MDS remains poorly understood. We therefore designed a
study combining conventional chromosome analysis, FISH, 
and immunophenotyping, as well as bone marrow culture 
studies, in two patients with MDS evolving into acute my- 
eloid leukemia (AML) with trisomy 8, to analyze the distri- 
bution of this numerical aberration i  different hemopoietic 
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lineages and to better understand its possible role in the nat- 
ural history of MDS undergoing transformation i to AML. 
PATIENTS AND METHODS 
Two patients with MDS evolving into AML carrying trisomy 
8 were studied. Diagnoses were made according to the FAB 
criteria [2, 7]. Cytogenetic, FISH studies, and in vitro assays 
of progenitor cell growth were performed as summarized 
below. 
Patient 1 
This 65-year-old patient was referred to our institute in Janu- 
ary 1992 for anemia nd splenomegaly (4 cm below left costal 
margin). The blood count revealed hemoglobin (Hb) 8 g/dL, 
platelet (Plt) 40 x 109/L, white blood cell (WBC) 2 x 109/L, 
with 3% blasts. The BM was hypercellular, with hyperpla- 
sia of the granulomonocytic l neage and relative reduction 
of the erythroid series (see Table 1). Nuclear as well cyto- 
plasmic dyserythropoiesis was apparent in 20% erythrob- 
lasts. The majority of neutrophils were hypogranular. 
Megakaryocytes were reduced and a moderate increase of 
lymphocytes and plasma cells was observed. Based on the 
presence of 27% blasts in the BM, a diagnosis of refractory 
anemia with excess of blasts in transformation (RAEB-t) was 
made. 
The patient required intensive supportive therapy 
throughout the course of the disease. Progressive reduction 
of mature forms of the gmnulocytic lineage concomitant with 
a gradual increase of blast cells was recorded over a 2-month 
period, resulting in leukemic switch with 45% BM blast cells 
with myelomonocytic features. 
Therapy with cytosine arabinoside (Ara-C) 10 mg/m 2, by 
intravenous infusion, twice a day for 10-14 clays was given. 
Six courses were administered between May 1992 and Apri l  
1993, obtaining only partial short-lasting reduction in the 
number of blast cells. Progressive spleen enlargement de- 
veloped and the patient died 18 months after diagnosis with 
disease progression. 
Patient 2 
This 67-year-old patient was admitted to our institute in Febru- 
ary 1992 for petechiae of the pelvic limbs. The blood count 
revealed pancytopenia: Hb 8.5 g/dL, Plt 50 x 109/L, WBC 
3 x 109/L, with 18% granulocytes, 76% lymphocytes, 4% 
monocytes, and 2 % blasts. The bone marrow sample, hyper- 
cellular with trilineage myelodysplasia, revealed 24% blasts. 
These findings were compatible with a diagnosis of RAEB-t. 
Progressive leftward shift of granulocytopoiesis with in- 
crease of BM blast cells to 38% was observed during a 
3-month period. Blast cells were occasionally granular and 
showed Sudan black-B positivity. These findings were con- 
sistent with a transformation f MDS into AML without matu- 
ration. Treatment with Ara-C, 10 mg/m 2, by intravenous in- 
fusion, twice a day for 7-10 days was administered. Eleven 
courses of low-dose Am-C were given between March 1992 
and October 1993, obtaining a reduction in the number of 
BM blast cells. The patient is presently alive and well, with 
a cytologic picture consistent with RAEB. 
Colony Assay 
In vitro growth of erythroid colonies (BFU-E) and of 
granulomonocytic colonies (CFU-GM) was assayed accord- 
ing to the methods described by Iscove et al. [8, 9]. In the 
BFU-E growth assay erythropoietin (Boehringer Mannheim) 
was added to give a final concentration of 2 U/ml. Recom- 
binant human granulocyte-macrophage colony-stimulating 
factor (rhGM-CSF, 10 ng/mL, Boehringer Mannheim, Ger- 
many) was used to stimulate growth of CFU-GM. 
Chromosome Studies on Bone Marrow Cells 
Bone marrow cells were cultured for 24 and 48 hours with- 
out mitogens. Synchronization with methotrexate and thymi- 
dine was performed. Metaphases were G-banded with 
Wright's tain. Chromosome aberrations were described ac- 
cording to the International System for Human Cytogenetic 
Nomenclature [10]. 
Cytogenetic Studies of Individual CFU-GM and BFU-E 
To analyze the karyotype of the progeny of single hemopoietic 
colonies grown in semisol id media and to assess the num- 
ber of BFU-E and CFU-GM with and without risomy 8, con- 
ventional cytogenetic as well as FISH studies of hemopoietic 
colonies were performed. Chromosome analysis from in- 
dividual  colonies were performed on days 8 to 10 for CFU- 
GM and on days 12 to 13 for BFU-E. Colcemid (100 ~tL of a 
Table 1 BM, cytogenetic, and interphase cytogenetic f indings in two patients with MDS evolving into AML 
Patient, % Bls/% GM cells/ No. abnormal/total no. 
sex/age (yr) % Ebls (BM) a Diagnosis BM karyotype metaphases 
No. of fluorescent 
spots in interphase 
cells b 
1 2 3 
1, M/65 27/53/11 RAEB-t 47,XY, + 8 25/43 6 42 52 
45/43/10 AML-M4 47,XY, + 8 33/39 8 21 71 
2, M/67 24/54/26 RAEB-t 47,Y,der(X)t(X;1)(q27;q25), + 8 16/23 6 41 53 
38/47/23 AML-M1 47,Y,der(X)t(X;1)(q27;q25), + 8 19/21 4 27 69 
Abbreviations: Bls, blast cells; GM cells, cells of the granulomonocytic lineage; Ebls, erythroblasts. 
° Differential on 300 BM cells; other cells were megakaryocytes, lymphocytes, and plasma cells. 
b 200 cells with well-delineated signals observed. Less than 1% cells with three spots were detected in a control slide from a normal subject. 
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0.1 p~g/mL solution) was added to cultures 6 hours prior to 
the end of the incubation period. Single colonies were indi- 
v idual ly aspirated and transferred into an Eppendorf  tube 
containing 80 I~L of 0.075 KCL. After incubation (30 minutes, 
37°C), the entire content of the Eppendorf tube was trans- 
ferred onto a microscope slide pre-treated with poly-L-lysine. 
The sl ides were incubated (30 minutes) in a moist chamber. 
Methanol/acetic a id (3:1) fixative was dropped onto the area 
of the slides where the colony was placed. The metaphases 
suitable for analysis were G-banded with Wright stain and 
karyotyped. 
The same procedure was adopted to prepare slides from 
single hemopoietic colonies for the purpose of FISH study 
(see below). 
Fluorescence In Situ Hybridization 
For the detection of trisomy 8 in interphase cells from BM 
samples and from single hemopoietic colonies, the chromo- 
some 8-specific entromeric probe (Oncor Inc., Gaithersburg, 
MD) was used. The percentage of interphase cells with 
trisomy 8 was assessed by FISH on BM cells at diagnosis and 
at leukemic switch in both patients. Sl ides prepared from 
BM samples for conventional cytogenetic analysis, aged at 
room temperature for 5-15 days, were treated with RNAse 
(RNAse A, 100 I~g/mL in 2 x SSC), dehydrated in alcohol, 
and denatured in 70% formamide at 70°C for 2 minutes. The 
biotinylated probe (100 ng/slide) was dissolved in 45 ~tL hy- 
bridization mixture (total volume) consisting of 60 % forma- 
mide in 2 x SSC, 10%wt/vol dextran sulphate, and 30 ~g 
salmon sperm DNA. 
Following denaturation at 75°C for 5 minutes, 45 ~tL of 
hybridization mixture were layered onto each slide. The 
slides were covered with a 24 x 50 mm coverslip and sealed 
with rubber cement (San.ford, Bellwood). Hybridization was 
allowed to proceed overnight at 37°C in a moist chamber. The 
slides were then washed in four changes of 50% formamide 
at 45°C for 3 minutes and in four changes of 2 x SSC at 45°C 
for 3 minutes. Following a 20-minute blocking step with 5 % 
non-fat dry milk powder in 2 x SSC, the slides were in- 
cubated with FITC-avidin (Vector, Burlingame, CA) (5 ~tg/mL 
in 4 x SSC/5% non-fat dry milk) for 20 minutes. 
Signal amplif ication was obtained with a layer of bio- 
tinylated anti-avidin monoclonal antibody (Vector, Burlin- 
game; 5 ~tg/mL), followed by incubation with FITC-avidin. 
Propidium iodide (0.5 ~g/mL) was used as a counterstain. 
Slides were examined under a fluorescence microscope (Di- 
aplan Leitz); 200 BM interphase cells with well-delineated 
fluorescent spots were counted in each patient for signal 
screening. At least 50 interphase cells from each single 
hemopoietic olony were observed. 
Combined Immunophenotyping and FISH 
To determine the percentage of erythroblasts, granulocyte 
precursors, and lymphocytes carrying trisomy 8, combined 
immunophenotype/FISH study was performed on BM cells 
at diagnosis. 
Following separation over a Ficoll  gradient, the 
mononuclear cells were incubated with the following mono- 
clonal antibodies: anti-CD13 (My7, Coulter Inc.) for granulo- 
cytic lineage, anti-CD14 (My4, Coulter Inc., Hialeah, FL) for 
mature monocytic ells, anti-glycophorin (OKRBC, Ortho 
Diagnostic System Inc., Raritan, NJ) for erythroid lineage, 
anti-CD2 (Tll, Dakopatts, Copenhagen, Denmark) labeling 
T lymphocytes, and anti-CD19 (Leu12, Becton-Dickinson, 
Mountain View, CA) labeling B lymphocytes. To minimize 
non-specific Fc binding, cell suspensions were preincubated 
with 5% normal rabbit serum (Dakopatts). 
Specific binding of the primary antibody was visualized 
with rabbit anti-mouse immunoglobul in conjugated with 
tetramethyl rhodamine isothiocyanate (TRITC) (Dakopatts). 
Cytospin preparations were made from each immunolabeled 
cell suspension and fixed by immersion for 30 minutes in 
methanol/acetic a id at a concentration 19:1 and by a sec- 
ond immersion for 15 minutes in methanol/acetic a id at a 
concentration 3:1. 
The same hybridization protocol as described above was 
employed for the detection of trisomy 8 in immunolabeled 
cells. No counterstaining was used. At least 100 immunola- 
beled cells with well-delineated signals were observed for 
each monoclonal antibody employed. 
RESULTS 
Cytogenetic and interphase cytogenetic f indings are de- 
scribed in Table 1. Results of combined innunophenotyping 
and DNA in situ hybridization and FISH on single colonies 
are presented in Tables 2 and 3. 
Chromosome studies on single colonies yielded 2-7 (me- 
Table 2 Progenitor assays and cytogenetic studies on individual  colonies in two patients 
with RAEB-t 
Patient Progenitor assays a Karyotype of individual colonies b 
diagnosis CFU-GM BFU-E CFU-GM BFU-E 
1 RAEB-t 90 42 47,XY, + 8 (4) 46,XY (20) 
46,XY (16) 
2 RAEB-t 105 20 47,Y,der(X), + 8 (3) 47,XY,der(X), + 8 (1) 
46,XY (15) 46,XY (19) 
Each value shows the mean of quadruplicate cultures. Normal value for CFU-GM: 120-200/105 BM mononuclear cells. Normal 
value for BFU-E, 70--120/105 BM cells. 
b Conventional cytogenetic analysis, number of colonies in parentheses. 
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dian 4) analyzable metaphases from each colony. The same 
karyotype was present in all metaphases obtained from a sin- 
gle colony. Salient results in each patient are summarized 
below. 
Patient 1 
Trisomy 8 was present in 25/43 of analyzed metaphases at
diagnosis, a figure confirmed by FISH studies revealing 52 % 
interphase cells with three fluorescent signals (Table 1). The 
relative size of the BM trisomic clone was found to be in- 
creased by FISH to 71% of all interphase cells at leukemic 
switch (p < 0.0001), when 33/39 metaphases with + 8 were 
obtained (see Table 1). 
Combined immunologic and FISH analyses howed three 
fluorescent signals in 49% CD13 + cells and in 39% CD14 + 
cells. Conversely, no positive cell with markers for the lym- 
phocyte and erythroid l ineage displayed three fluorescent 
signals. Cytogenetic analysis on single colonies howed the 
presence of 4/20 (20%) CFU-GM with trisomy 8, while this 
aberration was not present in any of the BFU-E cells exam- 
ined. Similar f indings were obtained by FISH on the single 
colonies, as shown in detail in Table 3. 
Figure 1 Combined FISH and immunophenotyping o  BM cells 
from patient 2: a CD13 + cell with three fluorescent signals using 
a chromosome 8-specific probe is shown. 
Patient 2 
A 47,Y, der(X)t(X;1)(q27;q25), + 8, karyotype was detected in 16 
of the 23 metaphases analyzed from BM samples at diagno- 
sis. FISH analysis revealed the presence of three fluorescent 
signals in 53% of the bone marrow cells. Trisomic cells in- 
creased to 69% in the leukemic phase (p = 0.001), when 19/21 
metaphases showed the same clonal abnormalit ies detected 
at diagnosis (see Table 1). Combined immunologic and FISH 
analysis (Fig. 1) demonstrated the presence of trisomy 8 in 
62% CD13 + cells, in 27% CD14 + cells, and in 21% OKRBC + 
cells. T and B lymphocytes did not have evidence of trisomy 8. 
Cytogenetic studies on single colonies revealed the pres- 
ence of the 47,Y, der(X)t(X;1)(q27;q25), + 8, karyotype in 3/18 
(16.6 %) of the CFU-GM, a f inding confirmed by FISH analy- 
sis showing 4/20 tr isomic CFU-GM. Evidence of trisomy 8 
in 1/10 and in 1/20 indiv idual  BFU-E was provided by FISH 
and by conventional chromosome analysis, respectively. 
Detailed results are summarized in Tables 2 and 3. 
DISCUSSION 
Although trisomy 8 is one of the most frequently occurring 
chromosome change in MDS, its role in the natural history 
of this primitive hemopoietic stem cell disorder emains elu- 
sive. Indeed, whi le debate still surrounds its possible prog- 
nostic significance [11, 12], reports showing mult i l ineage 
involvement by trisomy 8 in MDS with progressive accumu- 
lation of the trisomic clone in the BM have been publ ished 
[5, 6, 13, 14], along with studies documenting that fluctua- 
tions of the size of the trisomic clone may occur rather fre- 
quently without correlation with disease volution [15, 16]. 
By circumventing the need for metaphases, FISH enables 
cytogenetic study of adequate numbers of interphase cells, 
thus permitt ing the estimation of the clone size as well as 
the assessment ofthe distribution of chromosome aberrations 
in immunolabeled cells [17, 18]. In addit ion, the study of 
hemopoietic colonies grown in semisol id media can be eas- 
Table 3 Comparison of combined FISH and immunophenotyping with FISH on single 
hemopoiet ic olonies to assess l ineage involvement in two patients with RAEB-t 
Monoclonal 
antibody tested 
Signal screening 
in immunolabelled cells a 
1 2 3 
FISH on indiv idual  colonies b
No. of CFU-GM 
with three spots/ 
total no. assessed 
No. of BFU-E 
with three spots/ 
total no. assessed 
Patient 1 
Anti CD13 10 41 49 
Anti CD14 8 53 39 
Anti-glycop horine 9 91 0 
Patient 2 
Anti CD13 9 29 62 
Anti CD14 6 67 27 
Anti-glycophorine 10 69 21 
5/20 0/12 
4•20 1110 
a No CD2-positive and CD19-positive c lls with three signals were detected (100 cells observed). 
b More than 80% cells with three signals were found in each colony classified as trisomic; more than 80% cells with two signals 
were found in each colony classified as disomic. 
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ily performed by FISH, allowing for the comparison of the 
percent of trisomic cells in the in vitro culture system usu- 
ally adopted for colony assays and in uncultured BM samples. 
Because few patients with MDS and trisomy 8 have been 
studied, we designed this multiparameter analysis of the dis- 
tribution of trisomy 8 in erythroid, granulomonocytic, and 
lymphoid lineage in two patients with MDS evolving into 
AML. Discussion will focus on the issue of lineage involve- 
ment by trisomy 8 in these patients apparently running the 
same clinical course, and on the comparative analysis of the 
percentage oftrisomic ells in BM cells identified immuno- 
logically, as well as in single CFU-GM and BFU-E. 
Both disomic and trisomic ells were detected in BM cells 
in our patients by conventional chromosome analysis and 
by FISH, showing afairly good correspondence between the 
percentage ofmetaphase cells with trisomy 8 and the per- 
centage of interphase nuclei with three fluorescent signals. 
This finding confirms that FISH allows for the reliable de- 
tection of trisomy 8in interphase cells in MDS [19]. It is worth 
noting, however, that caution should be employed when in- 
terpreting these data since errors in assessing the abnormal- 
to-normal metaphase ratio may occur frequently [12]. In ad- 
dition, the FISH artefact rate has been shown recently to be 
relatively high, suggesting the need for an automated signal 
evaluation [20]. 
In view of the mosaicism of the disomic and trisomic lone 
in BM samples, itwas of interest to assess which cell popu- 
lation carried trisomy 8 in these patients. B and T lympho- 
cytes in our patient did not carry trisomy 8, as shown by com- 
bined FISH and immunophenotyping. This finding is in 
keeping with previous reports consistently showing that 
chromosome aberrations inMDS are usually restricted to the 
nonlymphoid lineage [21-23]. However, molecular genetic 
studies of the nature of lymphopoiesis in MDS have shown 
that lymphocytes may be part of the clonal proliferation in 
a fraction of MDS [24, 25], raising the possibility that clonal 
hemopoiesis may precede the development of chromosome 
aberrations in some patients [26]. 
Data obtained by combined immunophenotyping and 
FISH in this study provide evidence for the involvement of
the granulomonocytic lineage by trisomy 8 in our patients. 
By contrast, erythroid cells carrying trisomy 8 were only seen 
in patient 2, trisomic erythroblasts not having been detected 
by double FISH and immunophenotyping i  patient I in the 
present study. Different hypothetical scenarios may be en- 
visaged to account for the heterogeneity of lineage involve- 
ment by trisomy 8 in our two patients. 
Trisomy 8 may represent a clonal abnormality affecting 
a stem cell capable of differentiating along the granulomono- 
cytic pathway only, acquired uring the evolutive phases of 
MDS. In patient I, it is reasonable toassume that the clonal 
proliferation leading to refractory anemia was initially cytoge- 
netically normal and that trisomy 8 was acquired when pro- 
gressive accumulation of blast cells, later leading to overt 
leukemia, started to occur. This interpretation would explain 
why the erythroid lineage did not carry trisomy 8 and is in 
keeping with the evolution pattern of MDS previously de- 
scribed by Tricot et al. [27]. 
Alternatively, trisomy 8may be acquired in the early stages 
of the natural history of MDS and may involve a multipotent 
stem cell giving rise to a progeny of erythroblasts and gran- 
ulocytes. Data obtained from patient 2 suggest that the tri- 
somic clone may coexist with cytogenetically normal pro- 
genitors and that disease progression may occur, possibly 
due to a proliferative advantage ofthis chromosomally ab- 
normal clone. Indeed, a statistically significant increase in 
the percentage oftrisomic ells in BM samples was detected 
by FISH in our two patients when overt leukemia developed. 
The above considerations, along with the analysis of the 
clinical course in our two patients, which proved to be rather 
aggressive in patient 1 and indolent in patient 2, raise the 
issue of clinicobiologic heterogeneity of RAEB-t, a subset of 
MDS possibly including cases of %arly AML;' as well as gen- 
uine cases of preleukemia [28]. 
Consistent involvement of granulocyte precursors and 
erythroblasts bytrisomy 8 in MDS was reported in previous 
studies either using chromosome analysis of different cell 
populations obtained by separation on a density gradient [4], 
cytogenetic studies on progenitor cells [3], or chromosomal 
in situ suppression hybridization [13]. 
Two additional cases with trisomy 8 in cells of the 
granulomonocytic and erythroid lineage were recently found 
by combined immunophenotyping a d DNA in situ hybrid- 
ization [5, 6]. However, one patient with trisomy 8 that was 
confined to the erythroid lineage was also described [5], fur- 
ther increasing heterogeneity of lineage involvement by this 
chromosome aberration in MDS. 
In vitro growth of hemopoietic precursors i usually im- 
paired in MDS, reflecting disordered in vivo proliferation. 
Several mechanisms are likely to be involved in the genesis 
of this abnormal growth and the effect of clonal chromosome 
changes is unclear. Therefore, the presence of a mosaicism 
of a disomic and trisomic lone in our two cases prompted 
us to assess whether colonies growing in vitro originated from 
chromosomally normal cells or from trisomic progenitor 
cells. 
Conventional cytogenetic studies on single BFU-E and 
CFU-GM revealed that a proportion of erythroid and myeloid 
colonies originated from the cytogenetically abnormal stem 
cell in patient 2, in whom the involvement oferythroblasts 
and myelomonocytic cells was previously demonstrated by
combined FISH and immunophenotyping. 
In line with data deriving from combined immunophe- 
notyping and FISH, some trisomic CFU-GM and only cytoge- 
netically normal BFU-E were detected in patient I. In both 
patients, no additional clones with chromosome changes 
other than those found in direct cytogenetic harvest of BM 
samples were detected inprogenitor cells grown in semisolid 
medium. This culture system, therefore, does not appear to 
favor the preferential invitro growth of latent subclones with 
unrelated karyotypes, which have been shown recently to 
be detectable inMDS patients by a long-term BM culture sys- 
tem [29]. This finding is in keeping with a previous report 
[30]. 
For a better estimate of the number of trisomic progenitor 
cells growing in vitro in the MDS phase, we performed FISH 
on single colonies. In patient 2, the percentage of BFU-E and 
CFU-GM with trisomy 8 was lower than the percentage of
erythroblasts and granulocyte precursors showing three flu- 
orescent signals at combined immunologic/FISH analysis of 
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BM cells. Likewise, preferential growth of cytogenetically 
normal CFU-GM was demonstrated in patient 1. 
Therefore, this culture system may have facilitated the 
growth and differentiation of chromosomally normal pro- 
genitor cells over trisomic cells. Potentially, modifications 
of the routine culture system adopted in this study may be 
capable of further enhancing proliferation ofchromosomally 
normal progenitors. Swolin et al. [30] found in two MDS pa- 
tients with a 5q-  chromosome and with monosomy 7 a sig- 
nificantly lower proportion of chromosomally abnormal 
CFU-GM with respect to the proportion of abnormal 
metaphases in a direct BM preparation. Unlike our cases, 
a clone with trisomy 8 in a patient with MDS appeared to 
have growth advantage in vitro in comparison with normal 
clones. In this study, however, no information is provided 
concerning which cell lineage was involved by trisomy 8, 
making comparison with our data difficult. 
In conclusion, we have shown heterogeneity of lineage 
involvement by trisomy 8 in two patients with MDS employ- 
ing a combined immunophenotyping and DNA in situ hy- 
bridization technique and cytogenetic study of progenitor 
cells grown in semisolid media. Although preferential 
growth of chromosomally normal progenitor cells may oc- 
cur in vitro, the relative size of the trisomic lone increased 
at the time of leukemic switch, suggesting that a positive 
selective pressure allowed for the establishment and expan- 
sion of trisomic cells in vivo. 
This work was supported by M.U.R.S.T., fondi 40% and fondi 60%, 
and by Regione ER. This work is part of the Concerted Action: "Mo- 
lecular Cytogenetic Diagnosis in Hematological Malignancies" within 
the BMH1 program of the E.V.; CT 94-1703. 
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